Blackstone, Pfizer Partner to Fund Obesity Drug Development
Blackstone will provide up to $1.5 billion to fund Pfizer’s obesity drug development.
Related stories
Nvidia Shares Fall More Than 7% in Extended Trading
Nvidia shares fell more than 7% in Wednesday's extended session amid reports that the board could meet as soon as today to determine CEO Jensen Huang's fate.
M impact | EQUITY | Nov 11, 2026, 11:07 PM UTC
WSJ Reports Nvidia Board Is Preparing to Oust CEO Jensen Huang
The Wall Street Journal reports that Nvidia’s board is preparing to oust Huang over two extramarital affairs. The report says there is no clear succession plan.
M impact | EQUITY | Nov 11, 2026, 10:53 PM UTC
WSJ: Nvidia Board Preparing to Oust CEO Jensen Huang
The Wall Street Journal reported that Nvidia’s board is preparing to oust founder and CEO Jensen Huang. Directors could meet as soon as Wednesday to determine his future, the repor
M impact | EQUITY | Nov 11, 2026, 10:51 PM UTC
MoonLake Immunotherapeutics Shares Climb Roughly 8% Ahead of FDA Filing Deadline
MoonLake Immunotherapeutics shares rose roughly 8% on Wednesday as investors focused on an upcoming FDA acceptance deadline for its lead drug filing, sonelokimab.
M impact | EQUITY | Nov 11, 2026, 10:51 PM UTC
CoreWeave Shares Fall 5.7% After-Hours on Report of Possible Nvidia CEO Ouster
CoreWeave shares fell 5.7% after-hours after The Wall Street Journal reported that Nvidia's board is preparing to oust CEO Jensen Huang. CoreWeave is a major Nvidia customer, and N
M impact | EQUITY | Nov 11, 2026, 10:49 PM UTC
Arrow Minerals Secures A$5.5 Million Placement
M impact | EQUITY | Nov 11, 2026, 10:48 PM UTC